The U.S. Food and Drug Administration today approved several strengths of potassium chloride oral solution as the first generic drugs to receive a Competitive Generic Therapy (CGT) designation. This ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved diclofenac potassium for oral solution (Cambia, marketed by Kowa Pharmaceuticals America, Inc, under license from Applied ...

Lupin is introducing potassium chloride for oral solution in a dosage strength of 20 mEq. The company's product had previously been approved by the Food and Drug Administration. Lupin's product is the ...

Camber is offering sodium sulfate, potassium sulfate and magnesium sulfate oral solution. Sodium sulfate, potassium sulfate and magnesium sulfate oral solution is an osmotic laxative indicated for ...

Klor-Con Powder for oral solution is available as packets that contain 1.5g of potassium chloride (supplying potassium 20mEq and chloride 20mEq) in 30- and 100-count cartons. Upsher-Smith announced ...

MAPLE GROVE, Minn., Nov. 28, 2017 /PRNewswire/ -- Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON ® Powder (Potassium Chloride) for oral solution, 20 mEq. The ...

Xywav is the first FDA approved new treatment option indicated for both cataplexy and excessive daytime sleepiness in people living with narcolepsy in more than 15 years Xywav contains 92 percent less ...

DUBLIN, Feb. 16, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the completion of the rolling submission for the supplemental New Drug Application (sNDA) to the U.S. Food ...